-
1
-
-
0034612175
-
Inflammation and Alzheimer's disease
-
Akiyama, H., Barger, S. Barnum, S., Bradt, B., Bauer, J., Cole, G. M., Cooper, N. R., Eikelenboom, P., Emmerling, M., Fiebich, B. L., Finch, C. E., Frautschy, S., Griffin, W. S., Hampel, H., Hull, M., Landreth, G., Lue, L., Mrak, R., Mackenzie, I. R., McGeer, P. L., O'Banion, M. K., Pachter, J., Pasinetti, G., Plata-Salaman, C., Rogers, J., Rydel, R., Shen, Y., Streit, W., Strohmeyer, R., Tooyoma, I., Van Muiswinkel, F. L., Veerhuis, R., Walker, D., Webster, S., Wegrzyniak, B., Wenk, G., and Wyss-Coray, T. (2000). Inflammation and Alzheimer's disease. Neurobiol. Aging 21, 383-421.
-
(2000)
Neurobiol. Aging
, vol.21
, pp. 383-421
-
-
Akiyama, H.1
Barger, S.2
Barnum, S.3
Bradt, B.4
Bauer, J.5
Cole, G.M.6
Cooper, N.R.7
Eikelenboom, P.8
Emmerling, M.9
Fiebich, B.L.10
Finch, C.E.11
Frautschy, S.12
Griffin, W.S.13
Hampel, H.14
Hull, M.15
Landreth, G.16
Lue, L.17
Mrak, R.18
Mackenzie, I.R.19
McGeer, P.L.20
O'Banion, M.K.21
Pachter, J.22
Pasinetti, G.23
Plata-Salaman, C.24
Rogers, J.25
Rydel, R.26
Shen, Y.27
Streit, W.28
Strohmeyer, R.29
Tooyoma, I.30
Van Muiswinkel, F.L.31
Veerhuis, R.32
Walker, D.33
Webster, S.34
Wegrzyniak, B.35
Wenk, G.36
Wyss-Coray, T.37
more..
-
2
-
-
0942276496
-
PPARγ activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with type 2 diabetes
-
Bagi, Z., Koller, A., and Kaley, G. (2004). PPARγ activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with type 2 diabetes. Am. J. Physiol. Heart. Circ. Physiol. 286, H742-H748.
-
(2004)
Am. J. Physiol. Heart. Circ. Physiol.
, vol.286
-
-
Bagi, Z.1
Koller, A.2
Kaley, G.3
-
3
-
-
67349142021
-
Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease
-
Bell, R. D., and Zlokovic, B. V. (2009). Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol. 118, 103-113.
-
(2009)
Acta Neuropathol.
, vol.118
, pp. 103-113
-
-
Bell, R.D.1
Zlokovic, B.V.2
-
4
-
-
42049101837
-
Interference with PPARγ signaling causes cerebral vascular dysfunction, hypertrophy and remodeling
-
Beyer, A. M., Baumbach, G. L., Halabi, C. M., Modrick, M. L., Lynch, C. M., Gerhold, T. D., Ghoneim, S. M., de Lange, W. J., Keen, H. L., Tsai, Y. S., Maeda, N., Sigmund, C. D., and Faraci, F. M. (2008). Interference with PPARγ signaling causes cerebral vascular dysfunction, hypertrophy and remodeling. Hypertension 51, 867-871.
-
(2008)
Hypertension
, vol.51
, pp. 867-871
-
-
Beyer, A.M.1
Baumbach, G.L.2
Halabi, C.M.3
Modrick, M.L.4
Lynch, C.M.5
Gerhold, T.D.6
Ghoneim, S.M.7
de Lange, W.J.8
Keen, H.L.9
Tsai, Y.S.10
Maeda, N.11
Sigmund, C.D.12
Faraci, F.M.13
-
5
-
-
0035194145
-
Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide
-
Butterfield, D. A., Drake, J., Pocernich, C., and Castegna, A. (2001). Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends. Mol. Med. 7, 548-554.
-
(2001)
Trends. Mol. Med.
, vol.7
, pp. 548-554
-
-
Butterfield, D.A.1
Drake, J.2
Pocernich, C.3
Castegna, A.4
-
6
-
-
10044225937
-
Peroxisome proliferator-activated receptor γ induces a clearance mechanism for the amyloid-β peptide
-
Camacho, I. E., Serneels, L., Spittaels, K., Merchiers, P., Dominguez, D., and De Strooper, B. (2004). Peroxisome proliferator-activated receptor γ induces a clearance mechanism for the amyloid-β peptide. J. Neurosci. 24, 10908-10917.
-
(2004)
J. Neurosci.
, vol.24
, pp. 10908-10917
-
-
Camacho, I.E.1
Serneels, L.2
Spittaels, K.3
Merchiers, P.4
Dominguez, D.5
De Strooper, B.6
-
7
-
-
0035132330
-
PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation
-
Chawla, A., Barak, Y., Nagy, L., Liao, D., Tontonoz, P., and Evans, R. M. (2001). PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat. Med. 7, 48-52.
-
(2001)
Nat. Med.
, vol.7
, pp. 48-52
-
-
Chawla, A.1
Barak, Y.2
Nagy, L.3
Liao, D.4
Tontonoz, P.5
Evans, R.M.6
-
8
-
-
0027504874
-
Identification of two mPPAR related receptors and evidence for the existence of five subfamily members
-
Chen, F., Law, S. W., and O'Malley, B. W. (1993). Identification of two mPPAR related receptors and evidence for the existence of five subfamily members. Biochem. Biophys. Res. Commun. 196, 671-677.
-
(1993)
Biochem. Biophys. Res. Commun.
, vol.196
, pp. 671-677
-
-
Chen, F.1
Law, S.W.2
O'Malley, B.W.3
-
9
-
-
48749101255
-
Structural changes in Alzheimer's disease brain microvessels
-
Christov, A., Ottman, J., Hamdheydari, L., and Grammas, P. (2008). Structural changes in Alzheimer's disease brain microvessels. Curr. Alzheimer Res. 5, 392-395.
-
(2008)
Curr. Alzheimer Res.
, vol.5
, pp. 392-395
-
-
Christov, A.1
Ottman, J.2
Hamdheydari, L.3
Grammas, P.4
-
10
-
-
14844292619
-
Role of endothelin in fibrosis and anti-fibrotic potential of bosentan
-
Clozel, M., and Salloukh, H. (2005). Role of endothelin in fibrosis and anti-fibrotic potential of bosentan. Ann. Med. 37, 2-12.
-
(2005)
Ann. Med.
, vol.37
, pp. 2-12
-
-
Clozel, M.1
Salloukh, H.2
-
11
-
-
0034651101
-
Inflammatory mechanisms in Alzheimer's disease: inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists
-
Combs, C. K., Johnson, D. E., Karlo, J. C., Cannady, S. B., and Landreth, G. E. (2000). Inflammatory mechanisms in Alzheimer's disease: inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists. J. Neurosci. 20, 558-567.
-
(2000)
J. Neurosci.
, vol.20
, pp. 558-567
-
-
Combs, C.K.1
Johnson, D.E.2
Karlo, J.C.3
Cannady, S.B.4
Landreth, G.E.5
-
12
-
-
3042857903
-
Alzheimer's disease
-
Cummings, J. L. (2004). Alzheimer's disease. N. Engl. J. Med. 351, 59-67.
-
(2004)
N. Engl. J. Med.
, vol.351
, pp. 59-67
-
-
Cummings, J.L.1
-
13
-
-
33748755428
-
Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease
-
de la Monte, S. M., Tong, M., Lester-Coll, N., Plater, M. Jr., and Wands, J. R. (2006). Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease. J. Alzheimers Dis. 10, 89-109.
-
(2006)
J. Alzheimers Dis.
, vol.10
, pp. 89-109
-
-
de la Monte, S.M.1
Tong, M.2
Lester-Coll, N.3
Plater Jr., M.4
Wands, J.R.5
-
14
-
-
0037076294
-
Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-γ
-
Diep, Q. N., El Mabrouk, M., Cohn, J. S., Endemann, D., Amiri, F., Virdis, A., Neves, M. F., and Schiffrin, E. L. (2002). Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-γ. Circulation 105, 2296-2302.
-
(2002)
Circulation
, vol.105
, pp. 2296-2302
-
-
Diep, Q.N.1
El Mabrouk, M.2
Cohn, J.S.3
Endemann, D.4
Amiri, F.5
Virdis, A.6
Neves, M.F.7
Schiffrin, E.L.8
-
15
-
-
0026517010
-
Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
-
Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., and Wahli, W. (1992). Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68, 879-887.
-
(1992)
Cell
, vol.68
, pp. 879-887
-
-
Dreyer, C.1
Krey, G.2
Keller, H.3
Givel, F.4
Helftenbein, G.5
Wahli, W.6
-
16
-
-
85047691727
-
NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo
-
Eriksen, J., Sagi, S. A., Smith, T. E., Weggen, S., Das, P., McLendon, D. C., Ozols, V. V., Jessing, K. W., Zavitz, K. H., Koo, E. H., and Golde, T. E. (2003). NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo. J. Clin. Invest. 112, 440-449.
-
(2003)
J. Clin. Invest.
, vol.112
, pp. 440-449
-
-
Eriksen, J.1
Sagi, S.A.2
Smith, T.E.3
Weggen, S.4
Das, P.5
McLendon, D.C.6
Ozols, V.V.7
Jessing, K.W.8
Zavitz, K.H.9
Koo, E.H.10
Golde, T.E.11
-
17
-
-
77952423753
-
Rosiglitazone rescues memory impairment in Alzheimer's transgenic mice: mechanisms involving a reduced amyloid and tau pathology
-
doi: 10.1038/npp.2010.32
-
Escribano, L., Simón, A. M., Gimeno, E., Cuadrado-Tejedor, M., de Maturana, R. L., García-Osta, A., Ricobaraza, A., Pérez-Mediavilla, A., Río, J. D., and Frechilla, D. (2010). Rosiglitazone rescues memory impairment in Alzheimer's transgenic mice: mechanisms involving a reduced amyloid and tau pathology. Neuropsychopharmacology doi: 10.1038/npp.2010.32.
-
(2010)
Neuropsychopharmacology
-
-
Escribano, L.1
Simón, A.M.2
Gimeno, E.3
Cuadrado-Tejedor, M.4
de Maturana, R.L.5
García-Osta, A.6
Ricobaraza, A.7
Pérez-Mediavilla, A.8
Río, J.D.9
Frechilla, D.10
-
18
-
-
0035047718
-
Cerebral microvascular pathology in aging and Alzheimer's disease
-
Farkas, E., and Luiten, P. G. (2001). Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol. 64, 575-611.
-
(2001)
Prog. Neurobiol.
, vol.64
, pp. 575-611
-
-
Farkas, E.1
Luiten, P.G.2
-
19
-
-
20444497357
-
Receptor-independent actions of PPAR thiazolidinedione agonists: Is mitochondrial function the key?
-
Feinstein, D. L., Spagnolo, A., Akar, C., Weinberg, G., Murphy, P., Gavrilyuk, V., and Dello Russo, C. (2005). Receptor-independent actions of PPAR thiazolidinedione agonists: Is mitochondrial function the key? Biochem. Pharmacol. 70, 177-188.
-
(2005)
Biochem. Pharmacol.
, vol.70
, pp. 177-188
-
-
Feinstein, D.L.1
Spagnolo, A.2
Akar, C.3
Weinberg, G.4
Murphy, P.5
Gavrilyuk, V.6
Dello Russo, C.7
-
20
-
-
0037000396
-
Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier
-
Fiala, M., Liu, Q. N., Sayre, J., Pop, V., Brahmandam, V., Graves, M. C., and Vinters, H. V. (2002). Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier. Eur. J. Clin. Inv. 32, 360-371.
-
(2002)
Eur. J. Clin. Inv.
, vol.32
, pp. 360-371
-
-
Fiala, M.1
Liu, Q.N.2
Sayre, J.3
Pop, V.4
Brahmandam, V.5
Graves, M.C.6
Vinters, H.V.7
-
21
-
-
0035824518
-
Peroxisome proliferator-activated receptor γ inhibits transforming growth factor β-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3
-
Fu, M., Zhang, J., Zhu, X., Myles, D. E., Willson, T. M., Liu, X., and Chen, Y. E. (2001). Peroxisome proliferator-activated receptor γ inhibits transforming growth factor β-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3. J. Biol. Chem. 276, 45888-45894.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 45888-45894
-
-
Fu, M.1
Zhang, J.2
Zhu, X.3
Myles, D.E.4
Willson, T.M.5
Liu, X.6
Chen, Y.E.7
-
22
-
-
37549060702
-
Peroxisome proliferator-activated receptor γ up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis
-
Fuenzalida, K., Quintanilla, R., Ramos, P., Piderit, D., Fuentealba, R. A., Martinez, G., Inestrosa, N. C., and Bronfman, M. (2007). Peroxisome proliferator-activated receptor γ up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis. J. Biol. Chem. 282, 37006-37015.
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 37006-37015
-
-
Fuenzalida, K.1
Quintanilla, R.2
Ramos, P.3
Piderit, D.4
Fuentealba, R.A.5
Martinez, G.6
Inestrosa, N.C.7
Bronfman, M.8
-
23
-
-
0028078692
-
Altered cerebral energy metabolism in Alzheimer's disease: a PET study
-
Fukuyama, H., Ogawa, M., Yamauchi, H., Yamaguchi, S., Kimura, J., Yonekura, Y., and Konishi, J. (1994). Altered cerebral energy metabolism in Alzheimer's disease: a PET study. J. Nucl. Med. 35, 1-6.
-
(1994)
J. Nucl. Med.
, vol.35
, pp. 1-6
-
-
Fukuyama, H.1
Ogawa, M.2
Yamauchi, H.3
Yamaguchi, S.4
Kimura, J.5
Yonekura, Y.6
Konishi, J.7
-
24
-
-
33746662942
-
Pioglitazone does not increase cerebral glucose utilisation in a murine model of Alzheimer's disease and decreases it in wild-type mice
-
Galea, E., Feinstein, D. L., and Lacombe, P. (2006). Pioglitazone does not increase cerebral glucose utilisation in a murine model of Alzheimer's disease and decreases it in wild-type mice. Diabetologia 49, 2153-2161.
-
(2006)
Diabetologia
, vol.49
, pp. 2153-2161
-
-
Galea, E.1
Feinstein, D.L.2
Lacombe, P.3
-
25
-
-
7244226629
-
Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action
-
Gasparini, L., Ongini, E., and Wenk, G. (2004). Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action. J. Neurochem. 91, 521-536.
-
(2004)
J. Neurochem.
, vol.91
, pp. 521-536
-
-
Gasparini, L.1
Ongini, E.2
Wenk, G.3
-
26
-
-
33751548984
-
Overview of nomenclature of nuclear receptors
-
Germain, P., Staels, B., Dacquet, C., Spedding, M., and Laudet, V. (2006). Overview of nomenclature of nuclear receptors. Pharmacol. Rev. 58, 685-704.
-
(2006)
Pharmacol. Rev.
, vol.58
, pp. 685-704
-
-
Germain, P.1
Staels, B.2
Dacquet, C.3
Spedding, M.4
Laudet, V.5
-
27
-
-
0036098247
-
Cerebrovascular transforming growth factor-β contributes to inflammation in the Alzheimer's disease brain
-
Grammas, P., and Ovase, R. (2002). Cerebrovascular transforming growth factor-β contributes to inflammation in the Alzheimer's disease brain. Am. J. Pathol. 160, 1583-1587.
-
(2002)
Am. J. Pathol.
, vol.160
, pp. 1583-1587
-
-
Grammas, P.1
Ovase, R.2
-
28
-
-
58149265311
-
Pioglitazone improved cognition in a pilot study on patients with Alzheimer's disease and mild cognitive impairment with diabetes mellitus
-
Hanyu, H., Sato, T., Kiuchi, A., Sakurai, H., and Iwamoto, T. (2009). Pioglitazone improved cognition in a pilot study on patients with Alzheimer's disease and mild cognitive impairment with diabetes mellitus. J. Am. Geriatr. Soc. 57, 177-179.
-
(2009)
J. Am. Geriatr. Soc.
, vol.57
, pp. 177-179
-
-
Hanyu, H.1
Sato, T.2
Kiuchi, A.3
Sakurai, H.4
Iwamoto, T.5
-
29
-
-
20444499367
-
Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1-42 levels in APPV717I transgenic mice
-
Heneka, M. T., Sastre, M., Dumitrescu-Ozimek, L., Hanke, A., Dewachter, I., Kuiperi, C., O'Banion, K., Klockgether, T., Van Leuven, F., and Landreth, G. E. (2005). Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1-42 levels in APPV717I transgenic mice. Brain 128, 1442-1453.
-
(2005)
Brain
, vol.128
, pp. 1442-1453
-
-
Heneka, M.T.1
Sastre, M.2
Dumitrescu-Ozimek, L.3
Hanke, A.4
Dewachter, I.5
Kuiperi, C.6
O'Banion, K.7
Klockgether, T.8
Van Leuven, F.9
Landreth, G.E.10
-
30
-
-
0035800010
-
Relationship between metabolic dysfunctions, gene responses and delayed cell death after mild focal cerebral ischemia in mice
-
Hermann, D. M., Kilic, E., Hata, R., Hossmann, K. A., and Mies, G. (2001). Relationship between metabolic dysfunctions, gene responses and delayed cell death after mild focal cerebral ischemia in mice. Neuroscience 104, 947-955.
-
(2001)
Neuroscience
, vol.104
, pp. 947-955
-
-
Hermann, D.M.1
Kilic, E.2
Hata, R.3
Hossmann, K.A.4
Mies, G.5
-
31
-
-
0013854955
-
Nature of the hepatomegalic effect produced by ethyl-chloro-phenoxy-isobutyrate in the rat
-
Hess, R., Stäubli, W., and Riess, W. (1965). Nature of the hepatomegalic effect produced by ethyl-chloro-phenoxy-isobutyrate in the rat. Nature 208, 856-858.
-
(1965)
Nature
, vol.208
, pp. 856-858
-
-
Hess, R.1
Stäubli, W.2
Riess, W.3
-
32
-
-
17644438636
-
Decrease in parietal cerebral hemoglobin oxygenation during performance of a verbal fluency task in patients with Alzheimer's disease monitored by means of near-infrared spectroscopy (NIRS)-correlation with simultaneous rCBF-PET measurements
-
Hock, C., Villringer, K., Müller-Spahn, F., Wenzel, R., Heekeren, H., Schuh-Hofer, S., Hofmann, M., Minoshima, S., Schwaiger, M., Dirnagl, U., and Villringer, A. (1997). Decrease in parietal cerebral hemoglobin oxygenation during performance of a verbal fluency task in patients with Alzheimer's disease monitored by means of near-infrared spectroscopy (NIRS)-correlation with simultaneous rCBF-PET measurements. Brain Res. 755, 293-303.
-
(1997)
Brain Res.
, vol.755
, pp. 293-303
-
-
Hock, C.1
Villringer, K.2
Müller-Spahn, F.3
Wenzel, R.4
Heekeren, H.5
Schuh-Hofer, S.6
Hofmann, M.7
Minoshima, S.8
Schwaiger, M.9
Dirnagl, U.10
Villringer, A.11
-
33
-
-
13044287361
-
Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models
-
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G. Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., and Mucke, L. (1999). Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA 96, 3228-3233.
-
(1999)
Proc. Natl. Acad. Sci. USA
, vol.96
, pp. 3228-3233
-
-
Hsia, A.Y.1
Masliah, E.2
McConlogue, L.3
Yu, G.Q.4
Tatsuno, G.5
Hu, K.6
Kholodenko, D.7
Malenka, R.C.8
Nicoll, R.A.9
Mucke, L.10
-
34
-
-
70349329335
-
PPARα and PPARγ attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities
-
Huang, W., Eum, S. Y., András, I. E., Hennig, B., and Toborek, M. (2009). PPARα and PPARγ attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities. FASEB J. 23, 1596-1606.
-
(2009)
FASEB J.
, vol.23
, pp. 1596-1606
-
-
Huang, W.1
Eum, S.Y.2
András, I.E.3
Hennig, B.4
Toborek, M.5
-
35
-
-
15444367174
-
Peroxisome proliferator-activated receptor-{gamma} ligands regulate endothelial membrane superoxide production
-
Hwang, J., Kleinhenz, D. J., Lassègue, B., Griendling, K. K., Dikalov, S., and Hart, C. M. (2005). Peroxisome proliferator-activated receptor-{gamma} ligands regulate endothelial membrane superoxide production. Am. J. Physiol. Cell Physiol. 288, C899-C905.
-
(2005)
Am. J. Physiol. Cell Physiol.
, vol.288
-
-
Hwang, J.1
Kleinhenz, D.J.2
Lassègue, B.3
Griendling, K.K.4
Dikalov, S.5
Hart, C.M.6
-
36
-
-
34047263780
-
The PPARγ ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice
-
Hwang, J., Kleinhenz, D. J., Rupnow, H. L., Campbell, A. G., Thulé, P. M., Sutliff, R. L., and Hart, C. M. (2007). The PPARγ ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice. Vasc. Pharmacol. 46, 456-462.
-
(2007)
Vasc. Pharmacol.
, vol.46
, pp. 456-462
-
-
Hwang, J.1
Kleinhenz, D.J.2
Rupnow, H.L.3
Campbell, A.G.4
Thulé, P.M.5
Sutliff, R.L.6
Hart, C.M.7
-
37
-
-
2342614850
-
Neurovascular regulation in the normal brain and in Alzheimer's disease
-
Iadecola, C. (2004). Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Neurosci. Rev. 5, 347-360.
-
(2004)
Nat. Neurosci. Rev.
, vol.5
, pp. 347-360
-
-
Iadecola, C.1
-
38
-
-
0035936004
-
Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer's disease
-
In't Veld, B. A., Ruitenberg, A., Hofman, A., Launer, L. J., van Duijn, C. M., Stijnen, T., Breteler, M. M. B., and Stricker, B. H. C. (2001). Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer's disease. N. Engl. J. Med. 345, 1515-1521.
-
(2001)
N. Engl. J. Med.
, vol.345
, pp. 1515-1521
-
-
In't Veld, B.A.1
Ruitenberg, A.2
Hofman, A.3
Launer, L.J.4
van Duijn, C.M.5
Stijnen, T.6
Breteler, M.M.B.7
Stricker, B.H.C.8
-
39
-
-
13644271368
-
Peroxisome proliferator-activated receptor γ is expressed in hippocampal neurons and its activation prevents β-amyloid neurodegeneration: role of Wnt signaling
-
Inestrosa, N. C., Godoy, J. A., Quintanilla, R. A., Koenig, C. S., and Bronfman, M. (2005). Peroxisome proliferator-activated receptor γ is expressed in hippocampal neurons and its activation prevents β-amyloid neurodegeneration: role of Wnt signaling. Exp. Cell. Res. 304, 91-104.
-
(2005)
Exp. Cell. Res.
, vol.304
, pp. 91-104
-
-
Inestrosa, N.C.1
Godoy, J.A.2
Quintanilla, R.A.3
Koenig, C.S.4
Bronfman, M.5
-
40
-
-
0035180319
-
2+-superoxide dismutase and decrease p22phox message expression in primary endothelial cells
-
2+-superoxide dismutase and decrease p22phox message expression in primary endothelial cells. Metab. Clin. Exp. 50, 3-11.
-
(2001)
Metab. Clin. Exp.
, vol.50
, pp. 3-11
-
-
Inoue, I.1
Goto, S.2
Matsunaga, T.3
Nakajima, T.4
Awata, T.5
Hokari, S.6
Komoda, T.7
Katayama, S.8
-
41
-
-
0025132245
-
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
-
Issemann, I., and Green, S. (1990). Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347, 645-650.
-
(1990)
Nature
, vol.347
, pp. 645-650
-
-
Issemann, I.1
Green, S.2
-
42
-
-
0027525576
-
The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs
-
Issemann, I., Prince, R. A., Tugwood, J. D., and Green, S. (1993). The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J. Mol. Endocrinol. 11, 37-47.
-
(1993)
J. Mol. Endocrinol.
, vol.11
, pp. 37-47
-
-
Issemann, I.1
Prince, R.A.2
Tugwood, J.D.3
Green, S.4
-
43
-
-
0031888958
-
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
-
Jiang, C., Ting, A. T., and Seed, B. (1998). PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82-86.
-
(1998)
Nature
, vol.391
, pp. 82-86
-
-
Jiang, C.1
Ting, A.T.2
Seed, B.3
-
44
-
-
36949038203
-
The role of peroxisome proliferator-activated receptor-γ (PPARγ) in Alzheimer's disease
-
Jiang, Q., Heneka, M., and Landreth, G. E. (2008). The role of peroxisome proliferator-activated receptor-γ (PPARγ) in Alzheimer's disease. CNS Drugs 22, 1-14.
-
(2008)
CNS Drugs
, vol.22
, pp. 1-14
-
-
Jiang, Q.1
Heneka, M.2
Landreth, G.E.3
-
45
-
-
0024419325
-
Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease
-
Kalaria, R. N., and Harik, S. I. (1989). Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease. J. Neurochem. 53, 1083-1088.
-
(1989)
J. Neurochem.
, vol.53
, pp. 1083-1088
-
-
Kalaria, R.N.1
Harik, S.I.2
-
46
-
-
28844469924
-
Molecular mechanism of Nrf2 activation by oxidative stess
-
Kang, K. W., Lee, S. J., and Kim, S. G. (2005). Molecular mechanism of Nrf2 activation by oxidative stess. Antioxid. Redox Signal. 7, 1664-1673.
-
(2005)
Antioxid. Redox Signal.
, vol.7
, pp. 1664-1673
-
-
Kang, K.W.1
Lee, S.J.2
Kim, S.G.3
-
47
-
-
4243120941
-
Gene expression profiling of potential PPARγ target genes in mouse aorta
-
Keen, H. L., Ryan, M. J., Beyer, A., Mathur, S., Scheetz, T. E., Gackle, B. D., Faraci, F. M., Casavant, T. L., and Sigmund, C. D. (2004). Gene expression profiling of potential PPARγ target genes in mouse aorta. Physiol. Genomics 18, 33-42.
-
(2004)
Physiol. Genomics
, vol.18
, pp. 33-42
-
-
Keen, H.L.1
Ryan, M.J.2
Beyer, A.3
Mathur, S.4
Scheetz, T.E.5
Gackle, B.D.6
Faraci, F.M.7
Casavant, T.L.8
Sigmund, C.D.9
-
48
-
-
77951221502
-
Does peroxisome proliferator-activated receptor-γ (PPARγ) protect from hypertension directly through effects in the vasculature?
-
Ketsawatsomkron, P., Pelham, C. J., Groh, S., Keen, H. L., Faraci, F. M., and Sigmund, C. D. (2010). Does peroxisome proliferator-activated receptor-γ (PPARγ) protect from hypertension directly through effects in the vasculature? J. Biol. Chem. 285, 9311-9316.
-
(2010)
J. Biol. Chem.
, vol.285
, pp. 9311-9316
-
-
Ketsawatsomkron, P.1
Pelham, C.J.2
Groh, S.3
Keen, H.L.4
Faraci, F.M.5
Sigmund, C.D.6
-
49
-
-
0033608169
-
Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-γ in Alzheimer's disease brains
-
Kitamura, Y., Shimohama, S., Koike, H., Kakimura, J., Matsuoka, Y., Nomura, Y., Gebicke-Haerter, P. J., and Taniguchi, T. (1999). Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-γ in Alzheimer's disease brains. Biochem. Biophys. Res. Commun. 254, 582-586.
-
(1999)
Biochem. Biophys. Res. Commun.
, vol.254
, pp. 582-586
-
-
Kitamura, Y.1
Shimohama, S.2
Koike, H.3
Kakimura, J.4
Matsuoka, Y.5
Nomura, Y.6
Gebicke-Haerter, P.J.7
Taniguchi, T.8
-
50
-
-
0028321529
-
Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
-
Kliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., and Evans, R. M. (1994). Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA 91, 7355-7359.
-
(1994)
Proc. Natl. Acad. Sci. USA
, vol.91
, pp. 7355-7359
-
-
Kliewer, S.A.1
Forman, B.M.2
Blumberg, B.3
Ong, E.S.4
Borgmeyer, U.5
Mangelsdorf, D.J.6
Umesono, K.7
Evans, R.M.8
-
51
-
-
0006132932
-
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
-
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., and Lehmann, J. M. (1997). Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc. Natl. Acad. Sci. USA 94, 4318-4323.
-
(1997)
Proc. Natl. Acad. Sci. USA
, vol.94
, pp. 4318-4323
-
-
Kliewer, S.A.1
Sundseth, S.S.2
Jones, S.A.3
Brown, P.J.4
Wisely, G.B.5
Koble, C.S.6
Devchand, P.7
Wahli, W.8
Willson, T.M.9
Lenhard, J.M.10
Lehmann, J.M.11
-
52
-
-
39749188810
-
Cyclooxygenase-2 inhibition improves amyloid-β-mediated suppression of memory and synaptic plasticity
-
Kotilinek, L. A., Westerman, M. A., Wang, Q., Panizzon, K., Lim, G. P., Simonyi, A., Lesné, S., Falinska, A., Younkin, L. H., Younkin, S. G., Rowan, M., Cleary, J., Wallis, R. A., Sun, G. Y., Cole, G., Frautschy, S., Anwyl, R., and Ashe, K. H. (2008). Cyclooxygenase-2 inhibition improves amyloid-β-mediated suppression of memory and synaptic plasticity. Brain 131, 651-664.
-
(2008)
Brain
, vol.131
, pp. 651-664
-
-
Kotilinek, L.A.1
Westerman, M.A.2
Wang, Q.3
Panizzon, K.4
Lim, G.P.5
Simonyi, A.6
Lesné, S.7
Falinska, A.8
Younkin, L.H.9
Younkin, S.G.10
Rowan, M.11
Cleary, J.12
Wallis, R.A.13
Sun, G.Y.14
Cole, G.15
Frautschy, S.16
Anwyl, R.17
Ashe, K.H.18
-
53
-
-
74049099554
-
The relationship between Alzheimer's disease and diabetes: type 3 diabetes?
-
Kroner, Z. (2009). The relationship between Alzheimer's disease and diabetes: type 3 diabetes? Altern. Med. Rev. 14, 373-379.
-
(2009)
Altern. Med. Rev.
, vol.14
, pp. 373-379
-
-
Kroner, Z.1
-
54
-
-
4344586313
-
Effect of anti-inflammatory agents on transforming growth factor beta over-expressing mouse brains: a model revised
-
Lacombe, P., Mathews, P. M., Schmidt, S. D., Breidert, T., Heneka, M. T., Landreth, G. E., Feinstein, D., and Galea, E. (2004). Effect of anti-inflammatory agents on transforming growth factor beta over-expressing mouse brains: a model revised. J. Neuroinflammation 1, 11-27.
-
(2004)
J. Neuroinflammation
, vol.1
, pp. 11-27
-
-
Lacombe, P.1
Mathews, P.M.2
Schmidt, S.D.3
Breidert, T.4
Heneka, M.T.5
Landreth, G.E.6
Feinstein, D.7
Galea, E.8
-
55
-
-
46749115113
-
PPARγ agonists as therapeutics for the treatment of Alzheimer's disease
-
Landreth, G., Jiang, Q., Mandrekar, S., and Heneka, M. (2008). PPARγ agonists as therapeutics for the treatment of Alzheimer's disease. Neurotherapeutics 5, 481-489.
-
(2008)
Neurotherapeutics
, vol.5
, pp. 481-489
-
-
Landreth, G.1
Jiang, Q.2
Mandrekar, S.3
Heneka, M.4
-
56
-
-
62349097513
-
Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI)
-
Alzheimer's Disease Neuroimaging Initiative.
-
Langbaum, J. B., Chen, K., Lee, W., Reschke, C., Bandy, D., Fleisher, A. S., Alexander, G. E., Foster, N. L., Weiner, M. W., Koeppe, R. A., Jagust, W. J., and Reiman, E. M.; Alzheimer's Disease Neuroimaging Initiative. (2009). Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Neuroimage 45, 1107-1116.
-
(2009)
Neuroimage
, vol.45
, pp. 1107-1116
-
-
Langbaum, J.B.1
Chen, K.2
Lee, W.3
Reschke, C.4
Bandy, D.5
Fleisher, A.S.6
Alexander, G.E.7
Foster, N.L.8
Weiner, M.W.9
Koeppe, R.A.10
Jagust, W.J.11
Reiman, E.M.12
-
57
-
-
0031013395
-
Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs
-
Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M., and Kliewer, S. A. (1997). Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272, 3406-3410.
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 3406-3410
-
-
Lehmann, J.M.1
Lenhard, J.M.2
Oliver, B.B.3
Ringold, G.M.4
Kliewer, S.A.5
-
58
-
-
0029016829
-
An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ)
-
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., and Kliewer, S. A. (1995). An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J. Biol. Chem. 270, 12953-12956.
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 12953-12956
-
-
Lehmann, J.M.1
Moore, L.B.2
Smith-Oliver, T.A.3
Wilkison, W.O.4
Willson, T.M.5
Kliewer, S.A.6
-
59
-
-
33645038471
-
A specific amyloid-β protein assembly in the brain impairs memory
-
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., and Ashe, K. H. (2006). A specific amyloid-β protein assembly in the brain impairs memory. Nature 440, 352-357.
-
(2006)
Nature
, vol.440
, pp. 352-357
-
-
Lesné, S.1
Koh, M.T.2
Kotilinek, L.3
Kayed, R.4
Glabe, C.G.5
Yang, A.6
Gallagher, M.7
Ashe, K.H.8
-
60
-
-
38949208262
-
Plaque-bearing mice with reduced levels of oligomeric amyloid-β assemblies have intact memory function
-
Lesné, S., Kotilinek, L., and Ashe, K. H. (2008). Plaque-bearing mice with reduced levels of oligomeric amyloid-β assemblies have intact memory function. Neuroscience 151, 745-749.
-
(2008)
Neuroscience
, vol.151
, pp. 745-749
-
-
Lesné, S.1
Kotilinek, L.2
Ashe, K.H.3
-
61
-
-
0034254924
-
Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease
-
Lim, G. P., Yang, F., Chu, T., Chen, P., Beech, W., Teter, B., Tran, T., Ubeda, O., Ashe, K. H., Frautschy, S. A., and Cole, G. M. (2000). Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J. Neurosci. 20, 5709-5714.
-
(2000)
J. Neurosci.
, vol.20
, pp. 5709-5714
-
-
Lim, G.P.1
Yang, F.2
Chu, T.3
Chen, P.4
Beech, W.5
Teter, B.6
Tran, T.7
Ubeda, O.8
Ashe, K.H.9
Frautschy, S.A.10
Cole, G.M.11
-
62
-
-
0031057599
-
Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys
-
Maeshiba, Y., Kiyota, Y., Yamashita, K., Yoshimura, Y., Motohashi, M., and Tanayama, S. (1997). Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys. Arzneimittelforschung 47, 29-35.
-
(1997)
Arzneimittelforschung
, vol.47
, pp. 29-35
-
-
Maeshiba, Y.1
Kiyota, Y.2
Yamashita, K.3
Yoshimura, Y.4
Motohashi, M.5
Tanayama, S.6
-
63
-
-
33644687456
-
Short-term pioglitazone treatment improves vascular function irrespective of metabolic changes in patients with type 2 diabetes
-
Martens, F. M., Visseren, F. L., de Koning, E. J., and Rabelink, T. J. (2005). Short-term pioglitazone treatment improves vascular function irrespective of metabolic changes in patients with type 2 diabetes. J. Cardiovasc. Pharmacol. 46, 773-778.
-
(2005)
J. Cardiovasc. Pharmacol.
, vol.46
, pp. 773-778
-
-
Martens, F.M.1
Visseren, F.L.2
de Koning, E.J.3
Rabelink, T.J.4
-
64
-
-
0025332027
-
Anti-inflammatory drugs and Alzheimer disease
-
McGeer, P. L., McGeer, E., Rogers, J., and Sibley, J. (1990). Anti-inflammatory drugs and Alzheimer disease. Lancet 335, 1037.
-
(1990)
Lancet
, vol.335
, pp. 1037
-
-
McGeer, P.L.1
McGeer, E.2
Rogers, J.3
Sibley, J.4
-
65
-
-
33646126924
-
A decade of modeling Alzheimer's disease in transgenic mice
-
McGowan, E., Eriksen, J., and Hutton, M. (2006). A decade of modeling Alzheimer's disease in transgenic mice. Trends Genet. 22, 281-289.
-
(2006)
Trends Genet.
, vol.22
, pp. 281-289
-
-
McGowan, E.1
Eriksen, J.2
Hutton, M.3
-
66
-
-
0037154974
-
Combinatorial control of gene expression by nuclear receptors and coregulators
-
McKenna, N. J., and O'Malley, B. W. (2002). Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108, 465-474.
-
(2002)
Cell
, vol.108
, pp. 465-474
-
-
McKenna, N.J.1
O'Malley, B.W.2
-
67
-
-
70149104503
-
The neural correlates of naming and fluency deficits in Alzheimer's disease: an FDG-PET study
-
Melrose, R. J., Campa, O. M., Harwood, D. G., Osato, S., Mandelkern, M. A., and Sultzer, D. L. (2009). The neural correlates of naming and fluency deficits in Alzheimer's disease: an FDG-PET study. Int. J. Geriatr. Psychiatry 24, 885-893.
-
(2009)
Int. J. Geriatr. Psychiatry
, vol.24
, pp. 885-893
-
-
Melrose, R.J.1
Campa, O.M.2
Harwood, D.G.3
Osato, S.4
Mandelkern, M.A.5
Sultzer, D.L.6
-
68
-
-
0345118108
-
Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS
-
Moreno, S., Farioli-Vecchioli, S., and Cerù, M. P. (2004). Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience 123, 131-145.
-
(2004)
Neuroscience
, vol.123
, pp. 131-145
-
-
Moreno, S.1
Farioli-Vecchioli, S.2
Cerù, M.P.3
-
69
-
-
19944406770
-
MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET
-
Mosconi, L., Perani, D., Sorbi, S., Herholz, K., Nacmias, B., Holthoff, V., Salmon, E., Baron, J. C., De Cristofaro, M. T., Padovani, A., Borroni, B., Franceschi, M., Bracco, L., and Pupi, A. (2004). MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology 63, 2332-2340.
-
(2004)
Neurology
, vol.63
, pp. 2332-2340
-
-
Mosconi, L.1
Perani, D.2
Sorbi, S.3
Herholz, K.4
Nacmias, B.5
Holthoff, V.6
Salmon, E.7
Baron, J.C.8
De Cristofaro, M.T.9
Padovani, A.10
Borroni, B.11
Franceschi, M.12
Bracco, L.13
Pupi, A.14
-
70
-
-
0034213718
-
High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation
-
Mucke, L., Masliah, E., Yu, G. Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., and McConlogue, L. (2000). High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050-4058.
-
(2000)
J. Neurosci.
, vol.20
, pp. 4050-4058
-
-
Mucke, L.1
Masliah, E.2
Yu, G.Q.3
Mallory, M.4
Rockenstein, E.M.5
Tatsuno, G.6
Hu, K.7
Kholodenko, D.8
Johnson-Wood, K.9
McConlogue, L.10
-
71
-
-
3242784885
-
Mechanism of the nuclear receptor molecular switch
-
Nagy, L., and Schwabe, J. W. R. (2004). Mechanism of the nuclear receptor molecular switch. Trends Biochem. Sci. 29, 317-324.
-
(2004)
Trends Biochem. Sci.
, vol.29
, pp. 317-324
-
-
Nagy, L.1
Schwabe, J.W.R.2
-
72
-
-
55249125525
-
Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor γ agonist
-
Nicolakakis, N., Aboulkassim, T., Ongali, B., Lecrux, C., Fernandes, P., Rosa-Neto, P., Tong, X. K., and Hamel, E. (2008). Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor γ agonist. J. Neurosci. 28, 9287-9296.
-
(2008)
J. Neurosci.
, vol.28
, pp. 9287-9296
-
-
Nicolakakis, N.1
Aboulkassim, T.2
Ongali, B.3
Lecrux, C.4
Fernandes, P.5
Rosa-Neto, P.6
Tong, X.K.7
Hamel, E.8
-
73
-
-
84899514040
-
-
38th Annual Meeting of the Society for Neurosciences. Abstract no. 102909.
-
Nicolakakis, N., Aboulkassim, T., Ongali, B., Lecrux, C., Fernandes, P., Tong, X. K., Sandoe, C., and Hamel, E. (2009) Reversal of cerebrovascular dysfunction by pioglitazone in APP and TGF mice: relevance to Alzheimer's disease cerebrovascular pathology. 38th Annual Meeting of the Society for Neurosciences. Abstract no. 102909.
-
(2009)
Reversal of cerebrovascular dysfunction by pioglitazone in APP and TGF mice: relevance to Alzheimer's disease cerebrovascular pathology
-
-
Nicolakakis, N.1
Aboulkassim, T.2
Ongali, B.3
Lecrux, C.4
Fernandes, P.5
Tong, X.K.6
Sandoe, C.7
Hamel, E.8
-
74
-
-
56649120697
-
Mechanisms underlying pioglitazone-mediated relaxation in isolated blood vessel
-
Nomura, H., Yamawaki, H., Mukohda, M., Okada, M., and Hara, Y. (2008). Mechanisms underlying pioglitazone-mediated relaxation in isolated blood vessel. J. Pharmacol. Sci. 108, 258-265.
-
(2008)
J. Pharmacol. Sci.
, vol.108
, pp. 258-265
-
-
Nomura, H.1
Yamawaki, H.2
Mukohda, M.3
Okada, M.4
Hara, Y.5
-
75
-
-
0032764016
-
Diabetes mellitus and the risk of dementia: The Rotterdam Study
-
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A., Hofman, A., and Breteler, M. M. (1999). Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53, 1937-1942.
-
(1999)
Neurology
, vol.53
, pp. 1937-1942
-
-
Ott, A.1
Stolk, R.P.2
van Harskamp, F.3
Pols, H.A.4
Hofman, A.5
Breteler, M.M.6
-
76
-
-
65949114415
-
2+ currents by PPAR-γ agonists in cultured hippocampal neurons
-
2+ currents by PPAR-γ agonists in cultured hippocampal neurons. J. Neurochem. 109, 1800-1811.
-
(2009)
J. Neurochem.
, vol.109
, pp. 1800-1811
-
-
Pancani, T.1
Phelps, J.T.2
Searcy, J.L.3
Kilgore, M.W.4
Chen, K.C.5
Porter, N.M.6
Thibault, O.7
-
77
-
-
26444471700
-
A sumoylation-dependent pathway mediating transrepression of inflammatory response genes by PPARγ
-
Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., and Glass, C. K. (2005). A sumoylation-dependent pathway mediating transrepression of inflammatory response genes by PPARγ. Nature 437, 759-763.
-
(2005)
Nature
, vol.437
, pp. 759-763
-
-
Pascual, G.1
Fong, A.L.2
Ogawa, S.3
Gamliel, A.4
Li, A.C.5
Perissi, V.6
Rose, D.W.7
Willson, T.M.8
Rosenfeld, M.G.9
Glass, C.K.10
-
78
-
-
33750454798
-
Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats
-
Pathan, A. R., Viswanad, B., Sonkusare, S. K., and Ramarao, P. (2006). Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats. Life Sci. 79, 2209-2216.
-
(2006)
Life Sci.
, vol.79
, pp. 2209-2216
-
-
Pathan, A.R.1
Viswanad, B.2
Sonkusare, S.K.3
Ramarao, P.4
-
79
-
-
33745234766
-
Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice
-
Pedersen, W. A., McMillan, P. J., Kulstad, J. J., Leverenz, J. B., Craft, S., and Haynatzki, G. R. (2006). Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice. Exp. Neurol. 199, 265-273.
-
(2006)
Exp. Neurol.
, vol.199
, pp. 265-273
-
-
Pedersen, W.A.1
McMillan, P.J.2
Kulstad, J.J.3
Leverenz, J.B.4
Craft, S.5
Haynatzki, G.R.6
-
80
-
-
40749103882
-
Activation of peroxisome proliferator-activated receptor γ (PPARγ) suppresses Rho GTPases in human brain microvascular endothelial cells and inhibits adhesion and transendothelial migration of HIV-1 infected monocytes
-
Ramirez, S. H., Heilman, D., Morsey, B., Potula, R., Haorah, J., and Persidsky, Y. (2008). Activation of peroxisome proliferator-activated receptor γ (PPARγ) suppresses Rho GTPases in human brain microvascular endothelial cells and inhibits adhesion and transendothelial migration of HIV-1 infected monocytes. J. Immunol. 180, 1854-1865.
-
(2008)
J. Immunol.
, vol.180
, pp. 1854-1865
-
-
Ramirez, S.H.1
Heilman, D.2
Morsey, B.3
Potula, R.4
Haorah, J.5
Persidsky, Y.6
-
81
-
-
0016709214
-
Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate
-
Reddy, J. K., and Krishnakantha, T. P. (1975). Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate. Science 190, 787-789.
-
(1975)
Science
, vol.190
, pp. 787-789
-
-
Reddy, J.K.1
Krishnakantha, T.P.2
-
82
-
-
47849123972
-
Intranasal insulin administration dose-dependently modulates verbal memory and plasma β-amyloid in memory-impaired older adults
-
Reger, M. A., Watson, G. S., Green, P. S., Baker, L. D., Cholerton, B., Fishel, M. A., Plymate, S. R., Cherrier, M. M., Schellenberg, G. D., Frey, W.H. 2nd., and Craft, S. (2008). Intranasal insulin administration dose-dependently modulates verbal memory and plasma β-amyloid in memory-impaired older adults. J. Alzheimers Dis. 13, 323-331.
-
(2008)
J. Alzheimers Dis.
, vol.13
, pp. 323-331
-
-
Reger, M.A.1
Watson, G.S.2
Green, P.S.3
Baker, L.D.4
Cholerton, B.5
Fishel, M.A.6
Plymate, S.R.7
Cherrier, M.M.8
Schellenberg, G.D.9
Frey II, W.H.10
Craft, S.11
-
83
-
-
33745266146
-
Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease
-
Risner, M. E., Saunders, A. M., Altman, J. F. B., Ormandy, G. C., Craft, S., Foley, I. M., Zvartau-Hind, M. E., Hosford, D. A., and Roses, A. D. (2006). Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. Pharmacogenomics J. 6, 246-254.
-
(2006)
Pharmacogenomics J.
, vol.6
, pp. 246-254
-
-
Risner, M.E.1
Saunders, A.M.2
Altman, J.F.B.3
Ormandy, G.C.4
Craft, S.5
Foley, I.M.6
Zvartau-Hind, M.E.7
Hosford, D.A.8
Roses, A.D.9
-
84
-
-
0031886864
-
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
-
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., and Glass, C. K. (1998). The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391, 79-82.
-
(1998)
Nature
, vol.391
, pp. 79-82
-
-
Ricote, M.1
Li, A.C.2
Willson, T.M.3
Kelly, C.J.4
Glass, C.K.5
-
85
-
-
0027332081
-
β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease
-
Roher, A. E., Lowenson, J. D., Clarke, S., Woods, A. S., Cotter, R. J., Gowing, E., and Ball, M. J. (1993). β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 10836-10840.
-
(1993)
Proc. Natl. Acad. Sci. USA
, vol.90
, pp. 10836-10840
-
-
Roher, A.E.1
Lowenson, J.D.2
Clarke, S.3
Woods, A.S.4
Cotter, R.J.5
Gowing, E.6
Ball, M.J.7
-
86
-
-
31544481458
-
Acetylcholine esterase inhibitor donepezil improves dynamic cerebrovascular regulation in Alzheimer patients
-
Rosengarten, B., Paulsen, S., Molnar, S., Kaschel, R., Gallhofer, B., and Kaps, M. (2006). Acetylcholine esterase inhibitor donepezil improves dynamic cerebrovascular regulation in Alzheimer patients. J. Neurol. 253, 58-64.
-
(2006)
J. Neurol.
, vol.253
, pp. 58-64
-
-
Rosengarten, B.1
Paulsen, S.2
Molnar, S.3
Kaschel, R.4
Gallhofer, B.5
Kaps, M.6
-
87
-
-
1442288375
-
PPARγ agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice
-
Ryan, M. J., Didion, S. P., Mathur, S., Faraci, F. M., and Sigmund, C. D. (2004). PPARγ agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice. Hypertension 43, 661-666.
-
(2004)
Hypertension
, vol.43
, pp. 661-666
-
-
Ryan, M.J.1
Didion, S.P.2
Mathur, S.3
Faraci, F.M.4
Sigmund, C.D.5
-
88
-
-
0242609178
-
Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-γ agonists modulate immunostimulated processing of amyloid precursor protein through regulation of β-secretase
-
Sastre, M., Dewachter, I., Landreth, G. E., Willson, T. M., Klockgether, T., van Leuven, F., and Heneka, M. T. (2003). Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-γ agonists modulate immunostimulated processing of amyloid precursor protein through regulation of β-secretase. J. Neurosci. 23, 9796-9804.
-
(2003)
J. Neurosci.
, vol.23
, pp. 9796-9804
-
-
Sastre, M.1
Dewachter, I.2
Landreth, G.E.3
Willson, T.M.4
Klockgether, T.5
van Leuven, F.6
Heneka, M.T.7
-
89
-
-
31044445398
-
Nonsteroidal anti-inflammtory drugs repress β-secretase gene promoter activity by the activation of PPARγ
-
Sastre, M., Dewachter, I., Rossner, S., Bogdanovic, N., Rosen, E., Borghgraef, P., Evert, B. O., Dumitrescu-Ozimek, L., Thal, D. R., Landreth, G., Walter, J., Klockgether, T., van Leuven, F., and Heneka, M. T. (2006). Nonsteroidal anti-inflammtory drugs repress β-secretase gene promoter activity by the activation of PPARγ. Proc. Natl. Acad. Sci. USA 103, 443-448.
-
(2006)
Proc. Natl. Acad. Sci. USA
, vol.103
, pp. 443-448
-
-
Sastre, M.1
Dewachter, I.2
Rossner, S.3
Bogdanovic, N.4
Rosen, E.5
Borghgraef, P.6
Evert, B.O.7
Dumitrescu-Ozimek, L.8
Thal, D.R.9
Landreth, G.10
Walter, J.11
Klockgether, T.12
van Leuven, F.13
Heneka, M.T.14
-
90
-
-
79959479102
-
Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease
-
in press. doi:10.1016/j.neurobiolaging.2009.10.009.
-
Sato, T, Hanyu, H, Hirao, K, Kanetaka, H, Sakurai, H, Iwamoto, T. (2009). Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease. Neurobiol. Aging in press. doi:10.1016/j.neurobiolaging.2009.10.009.
-
(2009)
Neurobiol. Aging
-
-
Sato, T.1
Hanyu, H.2
Hirao, K.3
Kanetaka, H.4
Sakurai, H.5
Iwamoto, T.6
-
91
-
-
0034930107
-
Thiazolidinediones and liver toxicity
-
Scheen, A. J. (2001). Thiazolidinediones and liver toxicity. Diabetes Metab. (Paris) 27, 305-313.
-
(2001)
Diabetes Metab. (Paris)
, vol.27
, pp. 305-313
-
-
Scheen, A.J.1
-
92
-
-
0035066332
-
Alzheimer's disease: genes, proteins, and therapy
-
Selkoe, D. J. (2001). Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81, 741-766.
-
(2001)
Physiol. Rev.
, vol.81
, pp. 741-766
-
-
Selkoe, D.J.1
-
93
-
-
0028241915
-
Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease
-
Simpson, I. A., Chundu, K. R., Davies-Hill, T., Honer, W. G., and Davies, P. (1994). Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Ann. Neurol. 35, 546-551.
-
(1994)
Ann. Neurol.
, vol.35
, pp. 546-551
-
-
Simpson, I.A.1
Chundu, K.R.2
Davies-Hill, T.3
Honer, W.G.4
Davies, P.5
-
94
-
-
9644275598
-
Modulation of nuclear factor-κB activity by indomethacin influences Aβ levels but not Aβ precursor protein metabolism in a model of Alzheimer's disease
-
Sung, S., Yang, H., Uryu, K., Lee, E. B., Zhao, L., Shineman, D., Trojanowski, J. Q., Lee, V. M., and Praticò, D. (2004). Modulation of nuclear factor-κB activity by indomethacin influences Aβ levels but not Aβ precursor protein metabolism in a model of Alzheimer's disease. Am. J. Pathol. 165, 2197-2206.
-
(2004)
Am. J. Pathol.
, vol.165
, pp. 2197-2206
-
-
Sung, S.1
Yang, H.2
Uryu, K.3
Lee, E.B.4
Zhao, L.5
Shineman, D.6
Trojanowski, J.Q.7
Lee, V.M.8
Praticò, D.9
-
95
-
-
0013935229
-
Response of hepatic microbodies to a hypolipidemic agent, ethyl chlorophenoxyisobutyrate (CPIB)
-
Svoboda, D. J., and Azarnoff, D. L. (1966). Response of hepatic microbodies to a hypolipidemic agent, ethyl chlorophenoxyisobutyrate (CPIB). J. Cell Biol. 30, 442-450.
-
(1966)
J. Cell Biol.
, vol.30
, pp. 442-450
-
-
Svoboda, D.J.1
Azarnoff, D.L.2
-
96
-
-
77249109792
-
Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1dE9 mouse model of Alzheimer's disease
-
Toledo, E. M., and Inestrosa, N. C. (2010). Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1dE9 mouse model of Alzheimer's disease. Mol. Psychiatry 15, 272-285.
-
(2010)
Mol. Psychiatry
, vol.15
, pp. 272-285
-
-
Toledo, E.M.1
Inestrosa, N.C.2
-
97
-
-
0032999475
-
Regional cholinergic denervation of cortical microvessels and nitric oxide synthase-containing neurons in Alzheimer's disease
-
Tong, X. K., and Hamel, E. (1999). Regional cholinergic denervation of cortical microvessels and nitric oxide synthase-containing neurons in Alzheimer's disease. Neuroscience 92, 163-175.
-
(1999)
Neuroscience
, vol.92
, pp. 163-175
-
-
Tong, X.K.1
Hamel, E.2
-
98
-
-
30644465969
-
Vascular remodeling versus amyloid β-induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimer's disease
-
Tong, X. K., Nicolakakis, N., Kocharyan, A., and Hamel, E. (2005). Vascular remodeling versus amyloid β-induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimer's disease. J. Neurosci. 25, 11165-11174.
-
(2005)
J. Neurosci.
, vol.25
, pp. 11165-11174
-
-
Tong, X.K.1
Nicolakakis, N.2
Kocharyan, A.3
Hamel, E.4
-
99
-
-
0028180070
-
mPPARγ2: tissue-specific regulator of an adipocyte enhancer
-
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., and Spiegelman, B. M. (1994). mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8, 1224-1234.
-
(1994)
Genes Dev.
, vol.8
, pp. 1224-1234
-
-
Tontonoz, P.1
Hu, E.2
Graves, R.A.3
Budavari, A.I.4
Spiegelman, B.M.5
-
100
-
-
33644592598
-
Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study
-
Watson, G., Cholerton, B., Reger, M., Baker, L., Plymate, S., Asthana, S., Fishel, M., Kulstad, J., Green, P., Cook, D., Kahn, S., Keeling, M., and Craft, S. (2005). Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am. J. Geriatr. Psychiatry 13, 950-958.
-
(2005)
Am. J. Geriatr. Psychiatry
, vol.13
, pp. 950-958
-
-
Watson, G.1
Cholerton, B.2
Reger, M.3
Baker, L.4
Plymate, S.5
Asthana, S.6
Fishel, M.7
Kulstad, J.8
Green, P.9
Cook, D.10
Kahn, S.11
Keeling, M.12
Craft, S.13
-
101
-
-
0035829592
-
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
-
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., Kang, D. E., Marquez-Sterling, N., Golde, T. E., and Koo, E. H. (2001). A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity. Nature 414, 212-216.
-
(2001)
Nature
, vol.414
, pp. 212-216
-
-
Weggen, S.1
Eriksen, J.L.2
Das, P.3
Sagi, S.A.4
Wang, R.5
Pietrzik, C.U.6
Findlay, K.A.7
Smith, T.E.8
Murphy, M.P.9
Bulter, T.10
Kang, D.E.11
Marquez-Sterling, N.12
Golde, T.E.13
Koo, E.H.14
-
102
-
-
0033900999
-
Chronic overproduction of transforming growth factor-β1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice
-
Wyss-Coray, T., Lin, C., Sanan, D. A., Mucke, L., and Masliah, E. (2000). Chronic overproduction of transforming growth factor-β1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. Am. J. Pathol. 156, 139-150.
-
(2000)
Am. J. Pathol.
, vol.156
, pp. 139-150
-
-
Wyss-Coray, T.1
Lin, C.2
Sanan, D.A.3
Mucke, L.4
Masliah, E.5
-
103
-
-
0030764732
-
Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease
-
Wyss-Coray, T., Masliah, E., Mallory, M., McConlogue, L., Johnson-Wood, K., Lin, C., and Mucke, L. (1997). Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease. Nature 389, 603-606.
-
(1997)
Nature
, vol.389
, pp. 603-606
-
-
Wyss-Coray, T.1
Masliah, E.2
Mallory, M.3
McConlogue, L.4
Johnson-Wood, K.5
Lin, C.6
Mucke, L.7
-
104
-
-
0041921071
-
Anti-inflammatory drug therapy alters β-amyloid processing and deposition in an animal model of Alzheimer's disease
-
Yan, Q., Zhang, J., Liu, H., Babu-Khan, S., Vassar, R., Biere, A. L., Citron, M., and Landreth, G. (2003). Anti-inflammatory drug therapy alters β-amyloid processing and deposition in an animal model of Alzheimer's disease. J. Neurosci. 23, 7504-7509.
-
(2003)
J. Neurosci.
, vol.23
, pp. 7504-7509
-
-
Yan, Q.1
Zhang, J.2
Liu, H.3
Babu-Khan, S.4
Vassar, R.5
Biere, A.L.6
Citron, M.7
Landreth, G.8
-
105
-
-
35848964569
-
Effectiveness of treatment with donepezil hydrochloride and changes in regional cerebral blood flow in patients with Alzheimer's disease
-
Yoshida, T., Ha-Kawa, S., Yoshimura, M., Nobuhara, K., Kinoshita, T., and Sawada, S. (2007). Effectiveness of treatment with donepezil hydrochloride and changes in regional cerebral blood flow in patients with Alzheimer's disease. Ann. Nucl. Med. 21, 257-265.
-
(2007)
Ann. Nucl. Med.
, vol.21
, pp. 257-265
-
-
Yoshida, T.1
Ha-Kawa, S.2
Yoshimura, M.3
Nobuhara, K.4
Kinoshita, T.5
Sawada, S.6
-
106
-
-
20544469044
-
Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts
-
Zafiriou, S., Stanners, S. R., Saad, S., Polhill, T. S., Poronnik, P., and Pollock, C. A. (2005). Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts. J. Am. Soc. Nephrol. 16, 638-645.
-
(2005)
J. Am. Soc. Nephrol.
, vol.16
, pp. 638-645
-
-
Zafiriou, S.1
Stanners, S.R.2
Saad, S.3
Polhill, T.S.4
Poronnik, P.5
Pollock, C.A.6
-
107
-
-
0028124577
-
Effects of pioglitazone on calcium channels in vascular smooth muscle
-
Zhang, F., Sowers, J. R., Ram, J. L., Standley, P. R., and Peuler, J. D. (1994). Effects of pioglitazone on calcium channels in vascular smooth muscle. Hypertension 24, 170-175.
-
(1994)
Hypertension
, vol.24
, pp. 170-175
-
-
Zhang, F.1
Sowers, J.R.2
Ram, J.L.3
Standley, P.R.4
Peuler, J.D.5
-
108
-
-
1842633872
-
Insulin and the insulin receptor in experimental models of learning and memory
-
Zhao, W. Q., Chen, H., Quon, M. J., and Alkon, D. L. (2004). Insulin and the insulin receptor in experimental models of learning and memory. Eur. J. Pharmacol. 490, 71-81.
-
(2004)
Eur. J. Pharmacol.
, vol.490
, pp. 71-81
-
-
Zhao, W.Q.1
Chen, H.2
Quon, M.J.3
Alkon, D.L.4
-
109
-
-
0027749599
-
Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver
-
Zhu, Y., Alvares, K., Huang, Q., Rao, M. S., and Reddy, J. K. (1993). Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver. J. Biol. Chem. 268, 26817-26820.
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 26817-26820
-
-
Zhu, Y.1
Alvares, K.2
Huang, Q.3
Rao, M.S.4
Reddy, J.K.5
-
110
-
-
34247343262
-
Microvascular injury and blood-brain barrier leakage in Alzheimer's disease
-
Zipser, B. D., Johanson, C. E., Gonzalez, L., Berzin, T. M., Tavares, R., Hulette, C. M., Vitek, M. P., Hovanesian, V., and Stopa, E. G. (2007). Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol. Aging 28, 977-986.
-
(2007)
Neurobiol. Aging
, vol.28
, pp. 977-986
-
-
Zipser, B.D.1
Johanson, C.E.2
Gonzalez, L.3
Berzin, T.M.4
Tavares, R.5
Hulette, C.M.6
Vitek, M.P.7
Hovanesian, V.8
Stopa, E.G.9
|